Model

Novartis considers new sales model for experimental cancer therapy

Novartis considers new sales model for experimental cancer therapy

By

Using a med-tech strategy may help stem concern about CAR T-cell technology's complicated distribution and anticipated high prices, said Novartis exec.

OPINION

Email Newsletters